White House Announces Deal to Cap Insulin Costs for Seniors
On May 26th, 2020, the Trump administration announced that 1,750 Medicare Part D drug plans and Medicare Advantage plans will cap insulin copays at $35 in 2021. This policy change has the potential to drastically lower out-of-pocket costs for Americans and reduce cost-related non-adherence to insulin.
Divergent Insulin Out-of-Pocket Costs for Medicare Enrollees and the Privately Insured
Reports published by the Kaiser Family Foundation and JAMA Internal Medicine examine insulin costs for Medicare enrollees and commercially insured individuals, respectively. Aggregate Medicare out-of-pocket costs quadrupled between 2007 and 2017, while commercially insured consumer costs were relatively flat.
Patients With Type 1 Diabetes Spend About $2,500 A Year in Health Care Costs
New research from researchers with the University of Michigan CHEAR Center shows that while out-of-pocket costs for insulin can be substantial, patients with diabetes often pay more overall for other diabetes-related supplies and services. The lead author advocates for removing barriers to high-value care.
No-Deductible Preventive Drugs Lower Costs, Increase Medication Use for Low-Income Diabetes Patients
Insurers Continue to Waive Customer Costs for Virus Tests, Care
Congress Said COVID-19 Tests Should Be Free - But Who's Paying?
Congress mandated there would be no out-of pocket costs for COVID-19 testing when the Families First Coronavirus Response Act and the CARES Act were passed. However, some employers with self-funded health plans don’t cover all costs associated with testing.
Health Insurance Providers Respond to COVID-19
America’s Health Insurance Plans (AHIP) has compiled a list of health insurance providers’ actions to ensure Americans can receive appropriate prevention, testing, and treatment services during the COVID-19 pandemic.
Michael Chernew Appointed as MedPAC Chair
Breaking the Mold: Designing Health Plans That Do Not Impede Delivery of High-Value Care
The American College of Cardiology published a synopsis of their December 2019 summit on insurance benefit design and increasing access to high-value care. Summit attendees called for clinically nuanced plan designs that shift volume away from costly low-value services to create headroom for evidence-based therapies, without increasing health costs.
Hospice Carve-In: Aligning Benefits with Patient and Family Needs
Please Help Support the V-BID Center
As a non-profit entity, the V-BID Center relies on fundraising to support our research, education, and policy efforts. Please help us continue our work by donating here. We truly appreciate your consideration.